Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-03

Clinical Trial Update: Bosentan in Children With Pulmonary Arterial Hypertension [Phase 3]

View source ↗

Summary

This Clinical Trial Update reports the completion of a Phase 3 study evaluating Bosentan in children with Pulmonary Arterial Hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bosentan (Bosentan)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED